Updated
SanofiSNY · Healthcare
$47.04+0.28%
Market cap$112.7B
IndustryDrug Manufacturers - General

Sanofi (SNY) Superinvestor holders

16 of the superinvestors we track hold Sanofi (SNY) in their latest 13F filings, $2.1B in total.

Summary

The largest holder is Dodge & Cox, with $1.2B, 0.6% of the portfolio.

In their latest quarter: 3 opened a new position, 7 added, 5 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Dodge & Cox Trimmed 28,088,274$1.2B 0.6%Q2 2026
Ken Fisher
Fisher Investments
Trimmed 9,597,228$396M 0.1%Q3 2026
Charles Brandes
Brandes Investment Partners, LP
Added 4,136,417$176M 1.2%Q2 2026
Mark Donovan
Boston Partners
Added 3,844,844$164M 0.1%Q2 2026
Steve Cohen
Point72 Asset Management
New position 820,078$35M 0.1%Q2 2026
Sarah Ketterer
Causeway Capital Management
Trimmed 804,056$34M 0.4%Q2 2026
Louis Bacon
Moore Capital Management
Added 329,779$14M 0.3%Q2 2026
Jeremy Grantham
GMO
Added 285,165$12M 0.0%Q2 2026
Cliff Asness
AQR Capital Management
Added 246,181$11M 0.0%Q2 2026
Ray Dalio
Bridgewater Associates
New position 206,873$9M 0.0%Q2 2026
Richard Pzena
Pzena Investment Management
Added 113,396$5M 0.0%Q3 2026
PRIMECAP Management
PRIMECAP Management Co
Held 97,168$4M 0.0%Q2 2026
Lee Ainslie
Maverick Capital
Added 51,572$2M 0.0%Q2 2026
Ken Tropin
Graham Capital Management
New position 39,723$2M 0.1%Q2 2026
Arrowstreet Capital Trimmed 17,713$755,637 0.0%Q2 2026
Fred DiSanto
Ancora Holdings
Trimmed 280$11,945 0.0%Q2 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 202616
Q1 202614
Q4 202517
Q3 202515
Q2 202516
Q1 202516
Q4 202419
Q3 202417

Questions about Sanofi

Which superinvestors own Sanofi?

16 of the superinvestors we track hold Sanofi (SNY) in their latest 13F filings, $2.1B in total. Dodge & Cox, Ken Fisher, Charles Brandes, Mark Donovan, Steve Cohen, Sarah Ketterer.

Who is the largest superinvestor holder of SNY?

The largest holder is Dodge & Cox, with $1.2B, 0.6% of the portfolio.

From Sanofi's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Sanofi and thousands of other companies, in one place. Free to start.